Literature DB >> 2248335

Antibiotic therapy for Bacillus species infections.

G N Kervick1, H W Flynn, E Alfonso, D Miller.   

Abstract

We reviewed 36 cases of culture-proven Bacillus species ocular infections occurring between September 1974 and December 1989. Kirby-Bauer disk sensitivities were available in 34 of the 36 cases (95%). All Bacillus species isolates were sensitive to the aminoglycoside antibiotics (N = 34) and to vancomycin hydrochloride (N = 32); resistance to clindamycin was found in four of 18 (22%) of tested isolates. Although B. cereus was uniformly sensitive to these antibiotics, resistance to clindamycin occurred in four cases in the non-B. cereus group. The microbroth dilution technique confirmed the Kirby-Bauer data. The aminoglycosides were uniformly effective, but the cephalosporins (first, second, and third generation drugs) were consistently ineffective against B. cereus and varied from sensitive to moderately sensitive for the non-B. cereus isolates. Our microbiologic laboratory findings suggest that vancomycin hydrochloride in combination with an aminoglycoside ensures more consistent antibiotic coverage of Bacillus species ocular infections.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2248335     DOI: 10.1016/s0002-9394(14)77068-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

Review 1.  Bacillus cereus endophthalmitis.

Authors:  D B David; G R Kirkby; B A Noble
Journal:  Br J Ophthalmol       Date:  1994-07       Impact factor: 4.638

2.  Reducing the Level of Undecaprenyl Pyrophosphate Synthase Has Complex Effects on Susceptibility to Cell Wall Antibiotics.

Authors:  Yong Heon Lee; John D Helmann
Journal:  Antimicrob Agents Chemother       Date:  2013-06-24       Impact factor: 5.191

3.  Experimental Bacillus cereus post-traumatic endophthalmitis and treatment with ciprofloxacin.

Authors:  D V Alfaro; J Davis; S Kim; F Bia; J F Bogard; J W Briggs; P E Liggett
Journal:  Br J Ophthalmol       Date:  1996-08       Impact factor: 4.638

4.  Intravenous cefazolin in penetrating eye injuries. I. Effects of trauma and multiple doses on intraocular delivery.

Authors:  D V Alfaro; P E Liggett
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-04       Impact factor: 3.117

5.  Bacillus species are present in chewing tobacco sold in the United States and evoke plasma exudation from the oral mucosa.

Authors:  Israel Rubinstein; Gerald W Pedersen
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

6.  Clostridium perfringens endophthalmitis.

Authors:  A M Abu el-Asrar; K F Tabbara
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

7.  Bacillus cereus efflux protein BC3310 - a multidrug transporter of the unknown major facilitator family, UMF-2.

Authors:  Jasmin K Kroeger; Karl Hassan; Aniko Vörös; Roger Simm; Massoud Saidijam; Kim E Bettaney; Andreas Bechthold; Ian T Paulsen; Peter J F Henderson; Anne-Brit Kolstø
Journal:  Front Microbiol       Date:  2015-10-12       Impact factor: 5.640

8.  Assessment and molecular characterization of Bacillus cereus isolated from edible fungi in China.

Authors:  Chengcheng Liu; Pengfei Yu; Shubo Yu; Juan Wang; Hui Guo; Ying Zhang; Junhui Zhang; Xiyu Liao; Chun Li; Shi Wu; Qihui Gu; Haiyan Zeng; Youxiong Zhang; Xianhu Wei; Jumei Zhang; Qingping Wu; Yu Ding
Journal:  BMC Microbiol       Date:  2020-10-14       Impact factor: 3.605

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.